Fundraising FoxREDMILE — 2016 Investments
3 investments dated 2016 · listed companies and verified rows first · show all
Genalyte develops Merlin, a real-time diagnostic system that performs laboratory testing directly in clinical settings and integrates results with electronic health records.
Digital HealthHardwareHealthtechMedical DevicesSan Diego, US
Co-investorsBioBritBoutique Venture PartnersClaremont Creek VenturesCLI VenturesFusionX VenturesHBM Healthcare Investments+7 more
Science37 operates a decentralized clinical trial platform supported by a network of medical directors across specialties including cardiology, neurology, psychiatry, pediatrics, and internal medicine.
BiotechDigital HealthHealthtechMedical Devices
Tyler Van Horn(Chief Executive Officer)inDebra Weinstein(Chief Medical Officer)in
Co-investorsGlynn Capital ManagementGV (Google Ventures)LifeSci Venture PartnersLux CapitalSanofi VenturesInertia Ventures
Syros Pharmaceuticals is a Massachusetts gene-control biotech developing small molecules that regulate disease gene expression.
BiotechCambridge, US
Nancy Simonian(CEO)Peter Wirth(Director)Mark Alles(Director)Philip Sharp(Director)Richard A. Young(Director)Sue Gail Eckhardt(Director)
Co-investorsAisling CapitalARCH Venture PartnersQuan CapitalAlexandriaAlly Bridge GroupBain Capital+11 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.